These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 23178654)
41. PKCdelta regulates endothelial basal barrier function through modulation of RhoA GTPase activity. Harrington EO; Shannon CJ; Morin N; Rowlett H; Murphy C; Lu Q Exp Cell Res; 2005 Aug; 308(2):407-21. PubMed ID: 15935342 [TBL] [Abstract][Full Text] [Related]
42. Aryl-hydrocarbon receptor-dependent alteration of FAK/RhoA in the inhibition of HUVEC motility by 3-methylcholanthrene. Chang CC; Tsai SY; Lin H; Li HF; Lee YH; Chou Y; Jen CY; Juan SH Cell Mol Life Sci; 2009 Oct; 66(19):3193-205. PubMed ID: 19649566 [TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms underlying the anti-proliferative and anti-migratory effects of folate on homocysteine-challenged rat aortic smooth muscle cells. Chou Y; Lin HC; Chen KC; Chang CC; Lee WS; Juan SH Br J Pharmacol; 2013 Aug; 169(7):1447-60. PubMed ID: 23424995 [TBL] [Abstract][Full Text] [Related]
44. The antiangiogenic effect of digitoxin is dependent on a ROS-elicited RhoA/ROCK pathway activation. Boscaro C; Schimdt G; Cignarella A; Dal Maso L; Bolego C; Trevisi L Biochem Pharmacol; 2024 Apr; 222():116049. PubMed ID: 38342347 [TBL] [Abstract][Full Text] [Related]
45. A complex of p190RhoGAP-A and anillin modulates RhoA-GTP and the cytokinetic furrow in human cells. Manukyan A; Ludwig K; Sanchez-Manchinelly S; Parsons SJ; Stukenberg PT J Cell Sci; 2015 Jan; 128(1):50-60. PubMed ID: 25359885 [TBL] [Abstract][Full Text] [Related]
46. Thromboxane A Eckenstaler R; Ripperger A; Hauke M; Braun H; Ergün S; Schwedhelm E; Benndorf RA Biochem Pharmacol; 2022 Jul; 201():115069. PubMed ID: 35525325 [TBL] [Abstract][Full Text] [Related]
47. Targeting CCL21-folic acid-upconversion nanoparticles conjugates to folate receptor-α expressing tumor cells in an endothelial-tumor cell bilayer model. Lee KY; Seow E; Zhang Y; Lim YC Biomaterials; 2013 Jul; 34(20):4860-71. PubMed ID: 23562047 [TBL] [Abstract][Full Text] [Related]
48. Role of Moesin in Advanced Glycation End Products-Induced Angiogenesis of Human Umbilical Vein Endothelial Cells. Wang Q; Fan A; Yuan Y; Chen L; Guo X; Huang X; Huang Q Sci Rep; 2016 Mar; 6():22749. PubMed ID: 26956714 [TBL] [Abstract][Full Text] [Related]
49. Role of p190RhoGAP in beta 2 integrin regulation of RhoA in human neutrophils. Dib K; Melander F; Andersson T J Immunol; 2001 May; 166(10):6311-22. PubMed ID: 11342655 [TBL] [Abstract][Full Text] [Related]
50. Cyclic AMP response element-binding protein prevents endothelial permeability increase through transcriptional controlling p190RhoGAP expression. Chava KR; Tauseef M; Sharma T; Mehta D Blood; 2012 Jan; 119(1):308-19. PubMed ID: 22049513 [TBL] [Abstract][Full Text] [Related]
51. Cell surface transglutaminase promotes RhoA activation via integrin clustering and suppression of the Src-p190RhoGAP signaling pathway. Janiak A; Zemskov EA; Belkin AM Mol Biol Cell; 2006 Apr; 17(4):1606-19. PubMed ID: 16452636 [TBL] [Abstract][Full Text] [Related]
52. Androgen receptor activation reduces the endothelial cell proliferation through activating the cSrc/AKT/p38/ERK/NFκB-mediated pathway. Huo YN; Yeh SD; Lee WS J Steroid Biochem Mol Biol; 2019 Nov; 194():105459. PubMed ID: 31470108 [TBL] [Abstract][Full Text] [Related]
53. Neurite outgrowth from PC12 cells by basic fibroblast growth factor (bFGF) is mediated by RhoA inactivation through p190RhoGAP and ARAP3. Jeon CY; Kim HJ; Morii H; Mori N; Settleman J; Lee JY; Kim J; Kim SC; Park JB J Cell Physiol; 2010 Sep; 224(3):786-94. PubMed ID: 20578246 [TBL] [Abstract][Full Text] [Related]
54. Androgen receptor activation inhibits endothelial cell migration in vitro and angiogenesis in vivo. Huo YN; Yang HY; Ke HY; Lin CY; Tsai CS Eur J Cell Biol; 2024 Dec; 103(4):151456. PubMed ID: 39288691 [TBL] [Abstract][Full Text] [Related]
55. Cannabinoids inhibit angiogenic capacities of endothelial cells via release of tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells. Ramer R; Fischer S; Haustein M; Manda K; Hinz B Biochem Pharmacol; 2014 Sep; 91(2):202-16. PubMed ID: 24976505 [TBL] [Abstract][Full Text] [Related]
56. Active RhoA Exerts an Inhibitory Effect on the Homeostasis and Angiogenic Capacity of Human Endothelial Cells. Hauke M; Eckenstaler R; Ripperger A; Ender A; Braun H; Benndorf RA J Am Heart Assoc; 2022 Jun; 11(12):e025119. PubMed ID: 35699166 [TBL] [Abstract][Full Text] [Related]
57. RhoA is down-regulated at cell-cell contacts via p190RhoGAP-B in response to tensional homeostasis. Ponik SM; Trier SM; Wozniak MA; Eliceiri KW; Keely PJ Mol Biol Cell; 2013 Jun; 24(11):1688-99, S1-3. PubMed ID: 23552690 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of human vascular endothelial cells proliferation by terbinafine. Ho PY; Liang YC; Ho YS; Chen CT; Lee WS Int J Cancer; 2004 Aug; 111(1):51-9. PubMed ID: 15185342 [TBL] [Abstract][Full Text] [Related]
59. Folic acid inhibits COLO-205 colon cancer cell proliferation through activating the FRα/c-SRC/ERK1/2/NFκB/TP53 pathway: in vitro and in vivo studies. Kuo CT; Chang C; Lee WS Sci Rep; 2015 Jun; 5():11187. PubMed ID: 26056802 [TBL] [Abstract][Full Text] [Related]
60. Nestin-mediated cytoskeletal remodeling in endothelial cells: novel mechanistic insight into VEGF-induced cell migration in angiogenesis. Liang ZW; Wang Z; Chen H; Li C; Zhou T; Yang Z; Yang X; Yang Y; Gao G; Cai W Am J Physiol Cell Physiol; 2015 Mar; 308(5):C349-58. PubMed ID: 25500739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]